Medtronic Reports 8.4% Yearly Sales Growth in Fiscal 2026

Medtronic reports 8.4% year-over-year sales growth in fiscal 2026, its highest in 10 years. The growth stems from disciplined portfolio execution and operational rigor. The company serves 70 health conditions across 150 countries and maintains a 67.59% gross margin, 3.48% dividend yield, and $105B market cap.